SCHEMBL3665282

SCHEMBL3665282

O=C(NC1CCN(Cc2ccccn2)C(I)C1)c1cc2ccc(OC3CCN(c4ccc(C(F)(F)F)cc4)CC3)cc2o1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 1/20 0.41
RAB9A P51151 2/20 0.40
NPC1 O15118 2/20 0.38
DRD4 P21917 2/20 0.38
SRPK1 Q96SB4 1/20 0.37
POLB P06746 1/20 0.37
KDM4E B2RXH2 1/20 0.37
HPGD P15428 1/20 0.37
LPL P06858 1/20 0.36
LIPC P11150 1/20 0.36
LIPG Q9Y5X9 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
PKM P14618 1/20 0.36
SLC5A7 Q9GZV3 1/20 0.36
SLC6A5 Q9Y345 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3667429 0.90 SLC6A4 (0.40) SLC6A4DRD4LPLLIPGSLC6A5
SCHEMBL648340 0.89 DRD4 (0.50) SLC6A4RAB9ANPC1DRD4SRPK1
SCHEMBL3662664 0.88 SLC6A5 (0.46) SLC6A4DRD4SRPK1SLC6A5
SCHEMBL3665362 0.87 PRKAA2 (0.40) SLC6A4DRD4LIPCLIPGSLC6A5
SCHEMBL3659196 0.86 RAB9A (0.39) RAB9ANPC1DRD4POLBLPL
SCHEMBL3665902 0.86 AR (0.41) SLC6A4DRD4SLC6A5
SCHEMBL3666339 0.85 SLC6A4 (0.40) SLC6A4DRD4SLC6A5
SCHEMBL3666568 0.85 PRKAA2 (0.40) SLC6A4DRD4SLC6A5
SCHEMBL3668577 0.84 SLC6A5 (0.45) SLC6A4DRD4SLC6A5
SCHEMBL648178 0.83 RAB9A (0.46) SLC6A4RAB9ANPC1DRD4SRPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2231600-A1 CARBOXAMIDE, SULFONAMIDE AND AMINE COMPOUNDS FOR METABOLIC DISORDERS Rigel Pharmaceuticals, Inc. (US) 2010-09-29 EP claimed
WO-2009065131-A1 CARBOXAMIDE, SULFONAMIDE AND AMINE COMPOUNDS FOR METABOLIC DISORDERS RIGEL PHARMACEUTICALS, INC. (US) 2009-05-22 WO claimed